Lumbar Discopathy Decompression with Lateral Interbody Fusion: Radiological and Clinical Outcomes

December 3, 2024 updated by: Grzegorz Guzik, Podkarpackie Oncological Center

Single-Level Lateral Lumbar Interbody Fusion in Author's Modification: Clinical and Radiographic Outcomes

The aim of the study was to introduce a single-segment lumbar spine decompression and fusion with intervertebral implants through modified by the authors lateral lumbar approach. Functional, surgical and radiographic outcomes was evaluated.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Podkarpackie
      • Brzozów, Podkarpackie, Poland, 38-500
        • Subcarpatian Oncology Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

We retrospectively reviewed the medical data of patients who underwent single-level LIF from January to December 2021 at the Orthopaedic Oncology Department in Brzozów and the Trauma and Orthopaedic Department in Stalowa Wola.

Description

Inclusion Criteria:

Single-segment L1-L4 spine discopathy.

Exclusion Criteria:

Any other spinal diseases. More than one level of discopathy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Single level decompression and LLIF
Patients with single-segment L1-L4 spine discopathy treated with lumbar spine fusion modified by the authors were included in this study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the quality of life
Time Frame: 3 months after the surgery
the quality of life according to the EQ-VAS - Euro-Quality of Life Visual Analoque Score
3 months after the surgery
the functional status - Karnofsky scale
Time Frame: 3 months after the surgery
patients' neurological status, functional status according to the Karnofsky scale
3 months after the surgery
the functional status Oswestry Disability Index
Time Frame: 3 months after the surgery
patients' neurological status, functional status according to the ODI - Oswestry Disability Index
3 months after the surgery
the intensity of pain
Time Frame: 3 months after the surgery
the intensity of pain according to the VAS - Visual AnalogueScale score
3 months after the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic Outcomes: The Cross-Sectional Area of the Spinal Canal
Time Frame: 3 months after the surgery
Based on pre- and postoperative MRI/RTG the following aspects were assessed: The Cross-Sectional Area of the Spinal Canal, the width and depth of disc extrusion, and the width of the lateral recesses of the spinal canal, anterior disc height lumbar lordosis angle and lumbar segmental angle.
3 months after the surgery
Radiographic Outcomes: The Height and Width of the Intervertebral Foramina
Time Frame: 3 months after the surgery
Based on pre- and postoperative MRI/RTG the following aspects were assessed: The Height and Width of the Intervertebral Foramina
3 months after the surgery
Radiographic Outcomes: lumbar segmental angle.
Time Frame: 3 months after the surgery
Based on pre- and postoperative MRI/RTG the following aspects were assessed: lumbar segmental angle.
3 months after the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

November 26, 2024

First Submitted That Met QC Criteria

December 3, 2024

First Posted (Estimated)

December 5, 2024

Study Record Updates

Last Update Posted (Estimated)

December 5, 2024

Last Update Submitted That Met QC Criteria

December 3, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 02-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The medical records of the patients who participated in the study cannot be shared based on the protection of natural persons with regard to the processing of personal data according to the guidelines of the European Data Protection Board.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spine Degeneration

Subscribe